Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

What makes me angry is the way some

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
bcgk Member Profile
 
Followed By 1
Posts 214
Boards Moderated 1
Alias Born 08/24/19
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/20/2019 12:14:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/20/2019 12:12:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/20/2019 9:26:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2019 9:06:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 11:35:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 8:31:48 AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 11/12/2019 7:07:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/7/2019 9:13:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 8:36:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 5:07:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2019 8:16:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:10:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:06:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:05:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:04:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:03:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/8/2019 5:26:49 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/3/2019 9:04:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 8:34:28 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/1/2019 6:01:12 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/30/2019 4:13:58 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 9/27/2019 6:02:58 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/19/2019 9:19:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/19/2019 8:39:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 5:14:14 PM
bcgk   Monday, 10/21/19 09:15:56 AM
Re: lorbas95 post# 47498
Post # of 49413 
What makes me angry is the way some blokes are expressing themselves.

CYDY misses every single timeline, SP on ATL, CEO always telling fairies in greatest colours, FDA obviously complaining.....and people sell CYDY as the one and only biotech stock with zero risk...as if BLA submission is guaranteed, as if approval is guaranteed etc.

CYDY stays a high-risk otc stock. Whether great science will ever be displayed in SP is absolutely uncertain. I suspect it's still a 50:50 stock....a stock that you have to be able to afford.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist